HANGZHOU, ZHEJIANG, CHINA, January 16, 2026 /EINPresswire.com/ -- The pharmaceutical industry is undergoing a period of ...

Bristol Myers Squibb, GSK and Merck are contributing drug ingredients as part of their deals with the White House but are ...

According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast projects the global active pharmaceutical ingredient market to expand from ...

For much of the past decade, drug shortages in the United States were treated as episodic disruptions. In 2024, that framing ...

TopGum Industries signed a binding letter of intent to acquire U.S.-based operations manufacturing pharmaceutical products and dietary supplements in gummy dosage form, marking TopGum’s entry into ...

The stock's 14-day relative strength index (RSI) is 82.46. For the uninitiated, a level above 70 is considered overbought or ...

Fifty-two percent of active pharmaceutical ingredients used in U.S. medications are made outside the country, according to an annual report from the FDA. The agency released its “Fiscal Year 2022 ...

Teva announced its intention to divest its active pharmaceutical ingredient business to maximize current and potential revenue streams. Fourth quarter and full year 2023 figures include the impact of ...

NORTH CHICAGO, Ill., Aug. 12, 2025 /PRNewswire/ -- AbbVie (ABBV) today announced a $195 million investment in its North Chicago, Illinois manufacturing plant to expand domestic active pharmaceutical ...

Aptar Pharma and Dianosic Announce Exclusive Partnership to Advance the Active Resorbable Intranasal Scaffold Platform for the Treatment of Chronic Allergic Rhinitis and Chronic Rhinosinusitis ...

MEMPHIS, Tenn.--(BUSINESS WIRE)--Active Implants LLC, a company that develops orthopedic implant solutions, today announced that it has reached an exclusive agreement with Geistlich Pharma AG to be ...